Click here to read the Cover Story, "Scleral approaches to presbyopia moving from niche to mainstream."
There is a lot of excitement around the new eye drops for presbyopia, which should hopefully become available in the U.S. in the next 1 to 2 years. The beauty of this pharmacological option is that patients can try the drops and determine how effective they are and how well they tolerate them before committing to long-term use. It is the least invasive and easiest way to reverse the symptoms of presbyopia and reduce (Read more...)
Uncategorized